ShareholdingMay 11, 2026, 04:08 PM
Byrn, Inc. control shifts to MEDO Healthcare LLC; new CEO appointed
AI Summary
Byrn, Inc. announced a change in control following MEDO Healthcare LLC's purchase of 10 million Series A-1 Preferred Stock shares from Custodian Ventures LLC for $175,000. This transaction grants MEDO Healthcare LLC 84.7% of the company's total voting power. Concurrently, David Lazar resigned from his positions, and John Leo was appointed as the new sole director and CEO, with Arthur Magee named CFO and Secretary.
Key Highlights
- MEDO Healthcare LLC acquired 10 million Series A-1 Preferred Shares from Custodian Ventures LLC for $175,000.
- Each Series A-1 Preferred Share carries voting power equal to 250 common shares.
- MEDO Healthcare LLC now holds 84.7% of Byrn, Inc.'s total voting power.
- David Lazar resigned as the sole officer and director of Byrn, Inc.
- John Leo was appointed as the new sole director and CEO of Byrn, Inc.
- Arthur Magee was appointed as CFO and Secretary of Byrn, Inc.